[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.220.120. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 1988

Acanthamoeba KeratitisPotential Role for Topical Clotrimazole in Combination Chemotherapy

Author Affiliations

From the Departments of Ophthalmology, University of Florida College of Medicine, Gainesville (Drs Driebe, Stern, Adi, and Komadina), and the Rush-Presbyterian-St Luke's Medical Center, Chicago, (Dr Epstein); and the Division of Parasitic Diseases, Centers for Disease Control, Atlanta (Dr Visvesvara).

Arch Ophthalmol. 1988;106(9):1196-1201. doi:10.1001/archopht.1988.01060140356031
Abstract

• Clotrimazole is an antifungal agent that has been shown to have excellent in vitro activity against most strains of Acanthamoeba. We encountered four patients who developed Acanthamoeba keratitis while wearing contact lenses that had been stored in homemade saline. Their medical treatment regimens included the use of topical 1% clotrimazole. In two patients in whom conventional therapy failed, clotrimazole was successful in controlling recurrent infection following penetrating keratoplasty. Two other patients were treated with clotrimazole as well as propamidine isethionate and neomycin sulfate-polymyxin B sulfate-gramicidin from the outset, and had an excellent response to medical therapy. In those patients who found the commercially available cream uncomfortable, a 1% clotrimazole suspension formulated in artificial tears was used and found to be well tolerated.

×